XML 20 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Share-based Compensation
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(
5
)
Share-Based Compensation
 
Share-based compensation is measured at the grant date based on the fair value of the award and is recognized as an expense over the requisite service period (the vesting period of the equity grant).
 
The Company issues share-based awards through several plans that are described in detail in the notes to the consolidated financial statements for the year ended
December 31, 2017.
The compensation cost charged against income for those plans is included in selling, general & administrative expenses as follows (in thousands):
 
    Three Months Ended
September 30,
  Nine Months Ended
September 30,
Share-based compensation related to:   2018   2017   2018   2017
Common stock grants   $
100
    $
100
    $
405
    $
405
 
Stock option grants    
9
     
4
     
143
     
130
 
Restricted Stock Unit awards ("RSUs")    
163
     
102
     
415
     
307
 
Total share-based compensation   $
272
    $
206
    $
963
    $
842
 
 
The total income tax benefit recognized in the condensed consolidated statements of income for share-based compensation arrangements was approximately
$289,000
and
$106,000
for the
three
-month periods ended
September 30, 2018
and
2017,
respectively, and approximately
$649,000
and
$441,000
for the
nine
-month periods ended
September 
30,
2018
and
2017,
respectively.
 
The following is a summary of stock option activity under all plans for the
nine
-month period ended
September 
30,
2018:
 
    Shares Under
Options
 
Weighted

Average

Exercise Price

(per share)
 
Weighted
Average
Remaining
Contractual
Life

(in years)
 
Aggregate
Intrinsic
Value

(in thousands)
Outstanding at December 31, 2017    
202,379
    $
18.23
     
 
     
 
 
Granted    
10,344
     
31.20
     
 
     
 
 
Exercised    
(78,680
)    
16.14
     
 
     
 
 
Outstanding at September 30, 2018    
134,043
    $
20.46
     
4.75
    $
2,183
 
Exercisable at September 30, 2018    
122,793
    $
19.71
     
4.80
    $
2,093
 
Vested and expected to vest at September 30, 2018    
134,043
    $
20.46
     
4.75
    $
2,183
 
 
On
June 6, 2018,
the Company granted options to its directors for the purchase of
10,344
shares of common stock at that day’s closing price of
$31.20.
The compensation expense related to these grants was determined as the fair value of the options using the Black-Scholes option pricing model based on the following assumptions:
 
Expected volatility    
27.7
%  
Expected dividends    
None
   
Risk-free interest rate    
2.70
%  
Exercise price   $
31.20
   
Expected term (in years)    
6.0
   
Weighted-average grant date fair value   $
10.15
   
 
The stock volatility for each grant is determined based on a review of the experience of the weighted average of historical daily price changes of the Company’s common stock over the expected option term, and the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the option. The expected term is estimated based on historical option exercise activity.
 
During the
nine
-month period ended
September 30, 2018
and
2017,
the total intrinsic value of all options exercised (i.e., the difference between the market price on the exercise date and the price paid by the employees to exercise the options) was approximately
$1.2
million and
$577,000,
respectively, and the total amount of consideration received by the Company from the exercised options was approximately
$1.3
million and
$802,000,
respectively. At its discretion, the Company allows option holders to surrender previously-owned common stock in lieu of paying the exercise price and withholding taxes. During the
nine
-month period ended
September 30, 2018,
no
shares were surrendered for this purpose. During the
nine
-month period ended
September 30, 2017,
6,511
shares were surrendered for this purpose at an average market price of
$26.45.
 
On
February 21, 2018,
the Company’s Compensation Committee approved the award of
$400,000,
payable in shares of common stock to the Company’s Chairman, Chief Executive Officer, and President under the
2003
Incentive Plan. Subject to his continued employment and the terms of his employment agreement, the shares will be issued in
December 2018.
 
The following table summarizes information about Restricted Stock Units (“RSUs”) activity during the
nine
-month period ended
September 30, 2018:
 
    Restricted
Stock Units
  Weighted Average
Award Date
Fair Value
Outstanding at December 31, 2017    
57,395
    $
21.03
 
Awarded    
29,867
     
29.30
 
Shares vested    
(16,050
)    
23.55
 
Outstanding at September 30, 2018    
71,212
    $
23.48
 
 
At the Company’s discretion, RSU holders are given the option to net-share settle to cover the required minimum withholding tax, and the remaining amount is converted into the equivalent number of common shares. During the
nine
-month periods ended
September 30, 2018
and
2017,
5,328
and
4,377
shares were surrendered at an average market price of
$27.60
and
$24.50,
respectively.
 
As of
September 30, 2018,
the Company had approximately
$1.2
million of unrecognized compensation expense that is expected to be recognized over a period of
3.5
years.